Metformin, Careprost, Sildenafil, Tadalafil

All product prices are in US dollars.
US Brand Name ACTOplus/ ACTOplus MET
Generic Name Pioglitazone/ XR Metformin
Other Brand Name Biodub-M, Mefomin P, MOPADAY HS
Packing 10
Manufacturer SUN PHARMACEUTICALS, Franco Indian, Macleods, Wockhardt
Form Tablets
Strength 15 mg/ 500 mg, 30 mg/ 500 mg, 15 mg/800mg

  • 30 tabs 15 mg/ 500 mg $12.30
  • 30 tabs 30 mg/ 500 mg $26.70
  • 30 tabs 15 mg/ 800 mg $24.90
Available online

Customers also bought

  • Generic  Actos, Pioglitazone Tablet

    Generic Name: Pioglitazone
    Form: Tablet
  • Generic Abilify, Aripiprazole Tablet

    Generic Name: Aripiprazole
    Form: Tab
  • Generic Arcoxia, Etoricoxib

    Generic Name: Etoricoxib
    Form: Tablet
  • Generic  Rifadin, Rifampicin Capsules

    Generic Name: Rifampicin
    Form: Capsules
  • Generic Kestine, Ebastine

    Generic Name: Ebastine
    Form: Tablet
  • Forxiga (Farxiga in US)

    Generic Name:Dapagliflozin
    Form: tablet
< >

1 1 1 1 1 1

Similar Product

  • Competact 

    Generic Name: Pioglitazone, Metformin
    Form: Tablet
  • Mopaday, Pioglitazone/ Metformin

    Generic Name: Pioglitazone/ Metformin
    Form: Tablets
< >

1 1

Details

Introduction

Pioglitazone and Metformin, combination of two oral diabetes medicines, help control blood sugar levels in people suffering with type-2 diabetes who do not use daily insulin injections. Pioglitazone, an oral antihyperglycemic agent is known for reducing insulin resistance and improving glycemic control whereas Metformin lowers the blood sugar level made by the liver. The medication is often prescribed to type 2 diabetes mellitus adult patients in addition to diet and exercise to improve glycemic control. Pioglitazone and Metformin is FDA approved medication and is manufactured by Sun Pharmaceuticals and Franco Indian and is available in strength of 15 mg to 500 mg and 30 mg to 500 mg.


Use

Pioglitazone/ Metformin is a combination of two oral diabetes medicine used in the treatment of diabetes mellitus or type-2 diabetes in patients who do not use daily insulin injections.


Side effects

Some of the common side effects associated with Pioglitazone/ Metformin tablets include: ? Indigestion & Nausea ? Headache ? Diarrhea ? Swelling & Rapid weight gain ? Stomach Pain It is not necessary for every patient taking this medication to experience any kind of side effects as most of the patients taking the medication do not experience any kind of side effects and in many patients some of the common side effects vanish with the continued usage of the medication. Patients who experience severe allergic reactions like rash, hives, itching or difficulty in breathing should immediately consult with the doctor.


storage

Metformin/Pioglitazone must be stored at 77 degrees F or 25 degrees C. However, storage at temperatures between 15 and 30 degrees C is permitted. The medication must be stored away from heat, moisture, and sunlight and must be kept out of the reach of children and pets.


Composition

Pioglitazone/ Metformin Tablets contain Metformin as their active ingredient.


Dosage and administration

The dosage and administration of Pioglitazone/ Metformin tablets depends upon the patient?s medical conditions. The dose of the medication varies from individual to individual and it usually depends on their medical history. The initial dose of Pioglitazone/ Metformin is 15 mg/500 mg once in day or 15 mg/850 mg tablet twice a day, which is gradually titrated after observing the therapeutic response. To obtain the best result of the medication it is advised to follow the exact dosage prescribed by the doctors.


Overdosage

In case of overdose patients should immediately consult with doctor to seek immediate medical attention. However, few symptoms of overdose include, difficult breathing, unusually cold feelings, pain or tenderness in muscle, irregular heartbeat, unusual drowsiness, stomach discomfort, weakness and tiredness.


Clinical performance

Although no studies had been conducted on the combination effect of Metformin/Pioglitazone tablet but the efficacy and safety of both the components separately had been established. The two clinical studies conducted on both the components have proved efficacy and safety of the medication. Both the medications have shown significant improvements in glycemic control and lowering blood sugar level.